Andrew Badley researcher
Badley, Andrew D.
VIAF ID: 56896865 (Personal)
Permalink: http://viaf.org/viaf/56896865
Preferred Forms
- 100 0 _ ‡a Andrew Badley ‡c researcher
- 200 _ | ‡a Badley ‡b Andrew D.
- 100 1 _ ‡a Badley, Andrew D.
- 100 1 _ ‡a Badley, Andrew D.
- 100 1 _ ‡a Badley, Andrew D.
-
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Analysis of HIV Protease Killing Through Caspase 8 Reveals a Novel Interaction Between Caspase 8 and Mitochondria | |
Anti-apoptotic mechanisms of HIV: lessons and novel approaches to curing HIV | |
Attenuated T-lymphocyte response to HIV therapy in individuals receiving HMG-CoA reductase inhibitors. | |
Augmented Curation of Unstructured Clinical Notes from a Massive EHR System Reveals Specific Phenotypic Signature of Impending COVID-19 Diagnosis | |
Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2 | |
Beneficial effect of TRAIL on HIV burden, without detectable immune consequences | |
The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases | |
Blockade of HERG channels by HIV protease inhibitors. | |
Can HIV Be Cured and Should We Try? | |
Cardiothoracic Transplant Recipient Mycoplasma hominis: An Uncommon Infection with Probable Donor Transmission. | |
Casp8p41 expression in primary T cells induces a proinflammatory response | |
Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation. | |
Casp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIV | |
CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ Phenotype. | |
Cell death during HIV infection | |
Correction: Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment | |
COVID-associated pediatric hospitalization and ICU admission trends across a multi-state health system and the broader US population | |
CXCR4 Tropic HIV-1 gp120 Inhibition of SDF-1α-Induced Chemotaxis Requires Lck and is Associated with Cofilin Phosphorylation | |
Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity | |
Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. | |
Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection | |
Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand | |
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study. | |
Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4 | |
Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice | |
The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak | |
HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum | |
HIV elite control is associated with reduced TRAILshort expression | |
HIV induces TRAIL sensitivity in hepatocytes | |
HIV Protease Cleavage of Procaspase 8 is Necessary for Death of HIV-Infected Cells | |
HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome. | |
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction | |
HIV VprR77Q mutation does not influence clinical response of individuals initiating highly active antiretroviral therapy | |
How much gp120 is there? | |
Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations. | |
Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor ligation requires both PKCalpha and PKCtheta | |
The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism | |
Increased thymic output in HIV-negative patients after antiretroviral therapy | |
Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication | |
Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor | |
Intracellular Casp8p41 content is inversely associated with CD4 T cell count | |
Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis | |
Isolation of a TRAIL antagonist from the serum of HIV-infected patients. | |
Longitudinal laboratory testing tied to PCR diagnostics in COVID-19 patients reveals temporal evolution of distinctive coagulopathy signatures | |
Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition | |
Making sense of how HIV kills infected CD4 T cells: implications for HIV cure | |
MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates | |
Mitochondrion-mediated apoptosis in HIV-1 infection | |
Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis | |
Pandemic : point-of-care pocket guide | |
Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells. | |
Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients | |
Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals. | |
Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C. | |
Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size | |
Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation | |
Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice | |
Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease | |
Resistance to apoptosis: mechanism for the development of HIV reservoirs. | |
SDF-1α degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory | |
Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41. | |
TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes | |
The TRAIL to viral pathogenesis: the good, the bad and the ugly | |
Transient loss of HIV-1 DNA in an HIV-1 positive patient after kidney transplantation: A case report. | |
Twenty years of human immunodeficiency virus care at the Mayo Clinic: Past, present and future | |
Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis |